Kurm Pharma ApS: Financial statements 2024
CVR: 39181274
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Kurm Pharma ApS (CVR 39181274) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 331,133 and a net result of DKK 602,189 compared with DKK 241,730 the year before. That is an increase of 263.9% compared with the year before. Equity in the 2024 report amounted to DKK 4,091,679. The solvency ratio was 59.6%.
- Gross Profit
- DKK 331,133
- Profit/Loss
- DKK 602,189
- Equity
- DKK 4,091,679
- Total Assets
- DKK 6,870,479
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 331 t. | 602 t. | 4.1 mio. | - |
| 2023 | - | 91 t. | 242 t. | 3.5 mio. | - |
| 2022 | - | 459 t. | 333 t. | 3.2 mio. | - |
| 2021 | - | 2.6 mio. | 2 mio. | 3.1 mio. | - |
| 2020 | - | 947 t. | 705 t. | 969 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of August 6, 2024, Steen Nordstrøm has joined the board of directors of Kurm Pharma ApS.
As of August 5, 2024, Steen Nordstrøm has left the board of directors of Kurm Pharma ApS.
As of July 9, 2024, Peter Vammen has left the board of directors of Kurm Pharma ApS.
Kurm Pharma ApS has published its annual report for 2023. Gross profit came to DKK 91,002, and the net result was DKK 241,730.
About Kurm Pharma ApS
Kurm Pharma ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jacob Gjelstrup and Jesper Gjelstrup. The board consists of Steen Nordstrøm (chair), Allan Christensen, Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Fitzrovia ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity in the 2025 report amounted to DKK 1,813,033.